Imipenem Anhydrous | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Imipenem Anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 13 USDMF, 3 CEP/COS, 2 JDMF, 1 EU WC, 3 KDMF, 3 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

46 FDF Dossiers, 13 FDA Orange Book, 10 Europe, 4 Canada, 7 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL;250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 500MG BASE/VIAL;500MG/VIAL

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 SPI Pharma

DIGITAL CONTENT

20 NEWS #PharmaBuzz

20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 10 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

16 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 2 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls

Filters

Filters

FILTER :

filter Order Code Reset all filters

1 All

01 1I0090000

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Product Main Page

01

EDQM, Council of Europe

Imipenem

PharmScience R&D

Not Confirmed

Contact us
to update this info